Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

There was a paragraph that referenced 2 external articles:

Moreover, according to a recent screening of 5,632 compounds (https://www.researchsquare.com/article/rs-23951/v1), including 3,488 compounds that have undergone clinical stage testing across 600 indications, only 19 compounds were identified as having an IC50 in the nanomolar (<1µM) range, as Brilacidin achieved, when tested against SARS-CoV-2.

Obviously brilacidin was not part of this screening of 5632 compounds. This article was posted back in April. On a different screening we know out of 11552 compounds tested, brilacidin showed promise as a covid19 treatment. Can't wait to see how the peer review doc takes this info and hopefully bumps up Brilacidin's status

[e-mail] - Bernhard Ellinger the corresponding author to that article